Research conducted by the Children’s Cardiology Institute, write Dni.ru . At the heart of the drug is a synthesized protein that supports the function of cardiac cells. A new medicine can prevent heart attacks and prolong the life of children who have heart disease diagnosed. The mechanism of action of the drug is based on blocking the activity of fiber-fibronectin, which contributes to the recovery of tissues after injuries, but after heart attacks that have a negative effect on vital tissues. Employees of the Institute believe that with the help of the drug, it will be possible to eliminate the negative consequences of seizures after treatment. The drug has already been tested on rodents and human heart cells (molecular therapy using a special protein). The next stage will be tests on large animals, after which the results will be analyzed.